Skip to main content
Equibles

David Clair

Head of Investor Relations

BIO-TECHNE Corp (TECH)

Equibles does not estimate personal net worth.

Get an email with a short summary when BIO-TECHNE Corp publishes a filing, an earnings call transcript or a press release.

Get TECH alerts

About David Clair

David Clair is recorded as Head of Investor Relations at BIO-TECHNE Corp (TECH). David Clair has spoken on 23 earnings calls across 1 company, most recently for BIO-TECHNE Corp on May 6, 2026. BIO-TECHNE Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BIO-TECHNE Corp includes Charles Kummeth (CEO), James T. Hippel (CFO), Kim Kelderman (COO and Board Member) and 7 others.

David Clair on recent calls

“On the call with me this morning are Kim Kelderman, President and Chief Executive Officer, and Jim Hipple, Chief Financial Officer of Biotechni. Before we begin, let me briefly cover our safe harbor statement.”
Head of Investor Relations, BIO-TECHNE Corp Q3 FY2026 Earnings Call ·
“On the call with me this morning are Kim Kelderman, President and Chief Executive Officer, and Jim Hipple, Chief Financial Officer of Biotechni. Before we begin, let me briefly cover our safe harbor statement.”
Head of Investor Relations, BIO-TECHNE Corp Q2 FY2026 Earnings Call ·
“On the call with me this morning are Kim Kelderman, President and Chief Executive Officer; and Jim Hippel, Chief Financial Officer of Bio-Techne. Before we begin, let me briefly cover our safe harbor statement.”
Head of Investor Relations, BIO-TECHNE Corp Q1 FY2026 Earnings Call ·
“On the call with me this morning are Kim Kelderman, President and Chief Executive Officer; and Jim Hippel, Chief Financial Officer of Bio-Techne. Before we begin, let me briefly cover our safe harbor statement.”
Head of Investor Relations, BIO-TECHNE Corp Q4 FY2025 Earnings Call ·
“On the call with me this morning are Kim Kelderman, President and Chief Executive Officer, and Jim Hippel, Chief Financial Officer of Bio-Techne. Before we begin, let me briefly cover our safe harbor statement.”
Head of Investor Relations, BIO-TECHNE Corp Q2 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at BIO-TECHNE Corp

Recent activity

Show 11 earlier activities